BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Banach DB, Peaper DR, Fortune BE, Emre S, Dembry LM. The clinical and molecular epidemiology of pre-transplant vancomycin-resistant enterococci colonization among liver transplant recipients. Clin Transplant 2016;30:306-11. [DOI: 10.1111/ctr.12690] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Lee IK, Sng YP, Li WF, Chen CL, Wang CC, Lin CC, Chen IL. Importance of daptomycin dosage on the clinical outcome in liver transplant recipients with vancomycin-resistant enterococci infection. J Chemother 2022;:1-8. [PMID: 35075978 DOI: 10.1080/1120009X.2022.2031470] [Reference Citation Analysis]
2 Joshi S, Shallal A, Zervos M. Vancomycin-Resistant Enterococci: Epidemiology, Infection Prevention, and Control. Infect Dis Clin North Am 2021;35:953-68. [PMID: 34752227 DOI: 10.1016/j.idc.2021.07.002] [Reference Citation Analysis]
3 McFarlane AC, Kabbani D, Bakal JA, Smith SW. Clinical impact of vancomycin-resistant enterococci colonization in nonliver solid organ transplantation and its implications for infection control strategies: A single-center, 10-year retrospective study. Transpl Infect Dis 2021;:e13747. [PMID: 34674357 DOI: 10.1111/tid.13747] [Reference Citation Analysis]
4 Chea N, Sapiano MRP, Zhou L, Epstein L, Guh A, Edwards JR, Allen-Bridson K, Russo V, Watkins J, Pouch SM, Magill SS. Rates and causative pathogens of surgical site infections attributed to liver transplant procedures and other hepatic, biliary, or pancreatic procedures, 2015-2018. Transpl Infect Dis 2021;:e13589. [PMID: 33617680 DOI: 10.1111/tid.13589] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Sarwar S, Koff A, Malinis M, Azar MM. Daptomycin perioperative prophylaxis for the prevention of vancomycin-resistant Enterococcus infection in colonized liver transplant recipients. Transpl Infect Dis 2020;22:e13280. [PMID: 32216015 DOI: 10.1111/tid.13280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Belga S, Chiang D, Kabbani D, Abraldes JG, Cervera C. The direct and indirect effects of vancomycin-resistant enterococci colonization in liver transplant candidates and recipients. Expert Rev Anti Infect Ther 2019;17:363-73. [PMID: 30977692 DOI: 10.1080/14787210.2019.1607297] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 Bartoletti M, Giannella M, Tedeschi S, Viale P. Multidrug-Resistant Bacterial Infections in Solid Organ Transplant Candidates and Recipients. Infectious Disease Clinics of North America 2018;32:551-80. [DOI: 10.1016/j.idc.2018.04.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
8 Froeschen F, Gajdiss M, Uebele J, Meilaender A, Hoerauf A, Exner M, Molitor E, Bierbaum G, Engelhart S, Bekeredjian-ding I. Rapid monitoring of vancomycin-resistant Enterococcus faecium in hospital departments by repetitive element palindromic polymerase chain reaction. Journal of Hospital Infection 2018;99:208-17. [DOI: 10.1016/j.jhin.2017.11.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Lewis JD, Barros AJ, Sifri CD. Comparison of risk factors and outcomes of daptomycin-susceptible and -nonsusceptible vancomycin-resistant Enterococcus faecium infections in liver transplant recipients. Transpl Infect Dis 2018;20:e12856. [PMID: 29427322 DOI: 10.1111/tid.12856] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
10 Hand J, Patel G. Multidrug-resistant organisms in liver transplant: Mitigating risk and managing infections. Liver Transpl. 2016;22:1143-1153. [PMID: 27228555 DOI: 10.1002/lt.24486] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
11 Knackstedt ED, Danziger-Isakov L. Infections in pediatric solid-organ transplant recipients. Semin Pediatr Surg 2017;26:199-205. [PMID: 28964474 DOI: 10.1053/j.sempedsurg.2017.07.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Simkins J, Morris MI, Camargo JF, Vianna R, Beduschi T, Abbo LM. Clinical outcomes of intestinal transplant recipients colonized with multidrug-resistant organisms: a retrospective study. Transpl Int 2017;30:924-31. [PMID: 28544183 DOI: 10.1111/tri.12987] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
13 Flokas ME, Karageorgos SA, Detsis M, Alevizakos M, Mylonakis E. Vancomycin-resistant enterococci colonisation, risk factors and risk for infection among hospitalised paediatric patients: a systematic review and meta-analysis. Int J Antimicrob Agents 2017;49:565-72. [PMID: 28336313 DOI: 10.1016/j.ijantimicag.2017.01.008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
14 Reyes K, Bardossy AC, Zervos M. Vancomycin-Resistant Enterococci: Epidemiology, Infection Prevention, and Control. Infect Dis Clin North Am 2016;30:953-65. [PMID: 27660091 DOI: 10.1016/j.idc.2016.07.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]